May 29, 2024

This February 14, 2022 article published by Epoch Times, Zachary Stieber reports on the next steps in a lawsuit filed by a whistleblower against Pfizer and two other companies that performed the clinical trial of Pfizer’s COVID vaccine, Ventavia, and ICON.

According to the report, Brook Jackson filed a False Claims Act Suit against the three companies and has recently been unsealed after the US Department of Justice declined to intervene on her behalf. [Jackson was featured in the article Whistleblower Working for Company Testing Pfizer COVID Vaccines Says Company Falsified Data, Engaged in Questionable Research Practices].

However, despite the government’s decision, Jackson’s resolve has not waned. In an interview with Epoch Times, she said, “We’re going to pursue the case without the help of the government…[The odds of success aren’t good, but] it’s just a chance I have to take. I just feel like somebody has to be held accountable.”

Epoch Times has included some of the documents included in the court filing in this article.

Editor’s Note: Why isn’t the US government interested in ensuring that Pfizer’s clinical data is genuinely beyond reproach? Is it afraid of discovering that Jackson’s claims are true?

We commend Jackson for continuing this fight despite the challenges that she is bound to experience in this lawsuit. We thank her for taking this path. Her success is the success of humanity and the downfall of those who have manipulated and dehumanized us.

[Edited March 3, 2022] A deeper analysis of the implications of this lawsuit was written by Michael Nevradakis, Ph.D. and published by the Children’s Health Defense last March 2, 2022. We encourage you to read the new article in full here:

Read original Article

Read Online

Click the button below if you wish to read the article on the website where it was originally published.

Read Offline

Click the button below if you wish to read the article offline.

1 thought on “Pfizer Trial Whistleblower Continues Lawsuit

Leave a Reply

Your email address will not be published. Required fields are marked *